Clinical Trial Update: Intratumoral CAN2109 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intratumoral CAN2109 in adults with solid tumors and lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• CAN2109

Snippet

Sponsor: Canwell Biotech Limited | Conditions: Solid Tumor, Lymphoma | Phase 1 | Status: RECRUITING